Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,351 | 59,634 | 26,591 | 100,297 | 0 |
| Marketable Securities | 37,439 | 10,497 | 88,143 | N/A | 0 |
| Receivables | N/A | 459 | 784 | 1,051 | 0 |
| TOTAL | $101,326 | $74,305 | $117,543 | $102,173 | $0 |
| Non-Current Assets | |||||
| PPE Net | 2,164 | 2,694 | 2,319 | 2,483 | 0 |
| Investments And Advances | 0 | 0 | 10,482 | 0 | 0 |
| Other Non-Current Assets | 4,051 | 1,503 | 371 | 431 | 0 |
| TOTAL | $6,215 | $4,197 | $13,172 | $2,914 | $N/A |
| Total Assets | $107,541 | $78,502 | $130,715 | $105,087 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 667 | N/A | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | 7,296 | 10,727 | 3,070 | 2,068 | 0 |
| Accrued Expenses | 8,986 | 12,375 | 6,944 | 3,428 | 0 |
| Other current liabilities | 87 | 127 | 232 | 159 | 0 |
| TOTAL | $24,070 | $69,425 | $31,881 | $28,386 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,201 | N/A | N/A | N/A | 0 |
| Deferred Revenues | 4,815 | 46,196 | 21,635 | 22,731 | N/A |
| Other Non-Current Liabilities | 952 | 282 | 67 | 299 | 0 |
| TOTAL | $5,153 | $282 | $28,840 | $37,870 | $N/A |
| Total Liabilities | $29,223 | $69,707 | $60,721 | $66,256 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,817 | 1,907 | 914 | N/A | N/A |
| Common Shares | 5 | 3 | 3 | 1 | 0 |
| Retained earnings | -192,374 | -164,166 | -97,878 | -59,171 | 0 |
| Other shareholders' equity | 25 | -8 | -149 | 94,450 | 0 |
| TOTAL | $78,318 | $8,795 | $69,994 | $38,831 | $0 |
| Total Liabilities And Equity | $107,541 | $78,502 | $130,715 | $105,087 | $0 |